# Independence Realty Trust, Inc.: financial statements, quarterly IRT · NYSE · CIK 1466085 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/irt.md) · [Financials](/companies/irt/financials.md) · [Filings](/companies/irt/filings.md) · [Insiders](/companies/irt/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/irt/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [169](/filings/0001466085-25-000021.md) | [167](/filings/0001466085-25-000021.md) | [161](/filings/0001437749-26-004376.md) | [158](/filings/0001437749-26-004376.md) | [160](/filings/0001437749-26-004376.md) | [161](/filings/0001437749-26-004376.md) | [161](/filings/0001437749-26-014234.md) | [162](/filings/0001437749-26-025677.md) | [167](/filings/0001437749-26-004376.md) | [167](/filings/0001437749-26-004376.md) | [165](/filings/0001437749-26-014234.md) | [167](/filings/0001437749-26-025677.md) | | Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Interest expense | $m | [22.0](/filings/0001466085-23-000123.md) | [23.5 d](/filings/0001466085-24-000023.md) | [20.6](/filings/0001466085-24-000054.md) | [17.5](/filings/0001437749-25-024203.md) | [18.3](/filings/0001437749-25-032428.md) | [19.8 d](/filings/0001437749-26-004376.md) | [19.3](/filings/0001437749-26-014234.md) | [18.8](/filings/0001437749-26-025677.md) | [20.5](/filings/0001437749-25-032428.md) | [20.4 d](/filings/0001437749-26-004376.md) | [20.7](/filings/0001437749-26-014234.md) | [21.6](/filings/0001437749-26-025677.md) | | Income tax | $m | [0.0](/filings/0001466085-24-000124.md) | [0.0 d](/filings/0001437749-26-004376.md) | [0.0](/filings/0001437749-25-014089.md) | [0.0](/filings/0001437749-25-024203.md) | [0.0](/filings/0001437749-25-032428.md) | [0.0 d](/filings/0001437749-26-004376.md) | [0.0](/filings/0001437749-26-014234.md) | [0.0](/filings/0001437749-25-024203.md) | [0.0](/filings/0001437749-25-032428.md) | [0.0 d](/filings/0001437749-26-004376.md) | [0.0](/filings/0001437749-26-014234.md) | [0.0 d](/filings/0001437749-26-025677.md) | | Net income | $m | [3.9](/filings/0001466085-25-000021.md) | [(40.5)](/filings/0001466085-25-000021.md) | [17.6](/filings/0001437749-26-004376.md) | [10.4](/filings/0001437749-26-004376.md) | [12.4](/filings/0001437749-26-004376.md) | [(1.0)](/filings/0001437749-26-004376.md) | [8.4](/filings/0001437749-26-014234.md) | [8.0](/filings/0001437749-26-025677.md) | [6.9](/filings/0001437749-26-004376.md) | [33.3](/filings/0001437749-26-004376.md) | [(0.1)](/filings/0001437749-26-014234.md) | [3.4](/filings/0001437749-26-025677.md) | | Diluted EPS | $ per share | [0.02](/filings/0001466085-25-000021.md) | [(0.18)](/filings/0001466085-25-000021.md) | [0.08](/filings/0001437749-26-004376.md) | [0.05](/filings/0001437749-26-004376.md) | [0.05](/filings/0001437749-26-004376.md) | [0.00](/filings/0001437749-26-004376.md) | [0.04](/filings/0001437749-26-014234.md) | [0.03](/filings/0001437749-26-025677.md) | [0.03](/filings/0001437749-26-004376.md) | [0.14](/filings/0001437749-26-004376.md) | [0.00](/filings/0001437749-26-014234.md) | [0.01](/filings/0001437749-26-025677.md) | | Basic EPS | $ per share | [0.02](/filings/0001466085-25-000021.md) | [(0.18)](/filings/0001466085-25-000021.md) | [0.08](/filings/0001437749-26-004376.md) | [0.05](/filings/0001437749-26-004376.md) | [0.05](/filings/0001437749-26-004376.md) | [0.00](/filings/0001437749-26-004376.md) | [0.04](/filings/0001437749-26-014234.md) | [0.03](/filings/0001437749-26-025677.md) | [0.03](/filings/0001437749-26-004376.md) | [0.14](/filings/0001437749-26-004376.md) | [0.00](/filings/0001437749-26-014234.md) | [0.01](/filings/0001437749-26-025677.md) | - Revenue: us-gaap:Revenues - Cost of revenue: not reported - Operating income: not reported - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [17.2](/filings/0001466085-24-000124.md) | [22.9](/filings/0001437749-26-004376.md) | [21.3](/filings/0001437749-25-014089.md) | [21.0](/filings/0001437749-25-024203.md) | [17.6](/filings/0001437749-25-032428.md) | [21.2](/filings/0001437749-26-004376.md) | [29.1](/filings/0001437749-26-014234.md) | [19.5](/filings/0001437749-26-025677.md) | [23.3](/filings/0001437749-25-032428.md) | [23.6](/filings/0001437749-26-025677.md) | [23.3](/filings/0001437749-26-014234.md) | [22.5](/filings/0001437749-26-025677.md) | | Total assets | $m | [6,578](/filings/0001466085-23-000123.md) | [6,280](/filings/0001466085-25-000021.md) | [5,973](/filings/0001466085-24-000054.md) | [5,940](/filings/0001466085-24-000092.md) | [5,948](/filings/0001466085-24-000124.md) | [6,058](/filings/0001437749-26-004376.md) | [5,983](/filings/0001437749-25-014089.md) | [5,963](/filings/0001437749-25-024203.md) | [6,093](/filings/0001437749-25-032428.md) | [6,022](/filings/0001437749-26-025677.md) | [6,099](/filings/0001437749-26-014234.md) | [6,092](/filings/0001437749-26-025677.md) | | Total liabilities | $m | [2,910](/filings/0001466085-23-000123.md) | [2,713](/filings/0001466085-25-000021.md) | [2,414](/filings/0001466085-24-000054.md) | [2,407](/filings/0001466085-24-000092.md) | [2,459](/filings/0001466085-24-000124.md) | [2,483](/filings/0001437749-26-004376.md) | [2,396](/filings/0001437749-25-014089.md) | [2,412](/filings/0001437749-25-024203.md) | [2,477](/filings/0001437749-25-032428.md) | [2,432](/filings/0001437749-26-025677.md) | [2,578](/filings/0001437749-26-014234.md) | [2,605](/filings/0001437749-26-025677.md) | | Long-term debt | $m | [2,716](/filings/0001466085-23-000123.md) | [2,549](/filings/0001466085-25-000021.md) | [2,277](/filings/0001466085-24-000054.md) | [2,253](/filings/0001466085-24-000092.md) | [2,287](/filings/0001466085-24-000124.md) | [2,334](/filings/0001437749-26-004376.md) | [2,254](/filings/0001437749-25-014089.md) | [2,250](/filings/0001437749-25-024203.md) | [2,296](/filings/0001437749-25-032428.md) | [2,281](/filings/0001437749-26-025677.md) | [2,434](/filings/0001437749-26-014234.md) | [2,443](/filings/0001437749-26-025677.md) | | Shareholders' equity | $m | [3,529](/filings/0001466085-23-000123.md) | [3,431](/filings/0001466085-25-000021.md) | [3,424](/filings/0001466085-24-000054.md) | [3,399](/filings/0001466085-24-000092.md) | [3,355](/filings/0001466085-24-000124.md) | [3,442](/filings/0001437749-26-004376.md) | [3,455](/filings/0001437749-25-014089.md) | [3,420](/filings/0001437749-25-024203.md) | [3,485](/filings/0001437749-25-032428.md) | [3,460](/filings/0001437749-26-025677.md) | [3,393](/filings/0001437749-26-014234.md) | [3,359](/filings/0001437749-26-025677.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [75.8 d](/filings/0001466085-24-000124.md) | [59.2 d](/filings/0001437749-26-004376.md) | [44.1](/filings/0001437749-25-014089.md) | [83.0 d](/filings/0001437749-25-024203.md) | [69.2 d](/filings/0001437749-25-032428.md) | [63.4 d](/filings/0001437749-26-004376.md) | [60.4](/filings/0001437749-26-014234.md) | [82.2 d](/filings/0001437749-26-025677.md) | [79.3 d](/filings/0001437749-25-032428.md) | [60.2 d](/filings/0001437749-26-004376.md) | [55.3](/filings/0001437749-26-014234.md) | [80.9 d](/filings/0001437749-26-025677.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $m | [35.9 d](/filings/0001466085-24-000124.md) | [35.9 d](/filings/0001437749-26-004376.md) | [36.1](/filings/0001437749-25-014089.md) | [36.0 d](/filings/0001437749-25-024203.md) | [36.0 d](/filings/0001437749-25-032428.md) | [36.0 d](/filings/0001437749-26-004376.md) | [37.2](/filings/0001437749-26-014234.md) | [36.9 d](/filings/0001437749-26-025677.md) | [39.7 d](/filings/0001437749-25-032428.md) | [40.6 d](/filings/0001437749-26-004376.md) | [40.6](/filings/0001437749-26-014234.md) | [40.0 d](/filings/0001437749-26-025677.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-014234.md) | [0.0 d](/filings/0001437749-26-025677.md) | not reported | not reported | [29.9](/filings/0001437749-26-014234.md) | [(0.0) d](/filings/0001437749-26-025677.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: not reported - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [223](/filings/0001466085-23-000123.md) | [225](/filings/0001466085-24-000054.md) | [225](/filings/0001466085-24-000092.md) | [225](/filings/0001466085-24-000124.md) | [225](/filings/0001437749-25-014089.md) | [225](/filings/0001437749-25-024203.md) | [226](/filings/0001437749-25-032428.md) | [232](/filings/0001437749-26-014234.md) | [234](/filings/0001437749-26-025677.md) | [234](/filings/0001437749-25-032428.md) | [236](/filings/0001437749-26-014234.md) | [236](/filings/0001437749-26-025677.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 235,744,567 at 2026-07-29, from the cover of the [10-Q filed 2026-08-04](/filings/0001437749-26-025677.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.